Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

FDA awards regenerative medicine advanced therapy designation to romyelocel-L

July 3, 2018

Ocugen initiates first pivotal trial of OCU-300 for ocular graft-versus-host disease

July 3, 2018

Cereno reports results from first clinical study of CS-1

July 3, 2018

Bacteriophages adjuvant therapy tested in patients with severe staphylococcal sepsis

July 3, 2018

Gazyva receives approval in Japan

July 3, 2018

Nipro applies for approval of human stem cell therapy product for spinal cord injury

July 3, 2018

Cell therapies wake up and smell the coffee

July 3, 2018

Separating the good, the bad and the indifferent in neurodegeneration

July 3, 2018

From Adam's rib to Miss Piggy's jaw

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...